title: Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.
abstract: Tumor-associated neutrophils contribute to neovascularization by supplying matrix metalloproteinase-9 (MMP-9), a protease that has been genetically and biochemically linked to induction of angiogenesis. Specific roles of inflammatory neutrophils and their distinct proMMP-9 in the coordinate regulation of tumor angiogenesis and tumor cell dissemination, however, have not been addressed. We demonstrate that the primary tumors formed by highly disseminating variants of human fibrosarcoma and prostate carcinoma recruit elevated levels of infiltrating MMP-9-positive neutrophils and concomitantly exhibit enhanced levels of angiogenesis and intravasation. Specific inhibition of neutrophil influx by interleukin 8 (IL-8) neutralization resulted in the coordinated diminishment of tumor angiogenesis and intravasation, both of which were rescued by purified neutrophil proMMP-9. However, if neutrophil proMMP-9, naturally devoid of tissue inhibitor of metalloproteinases (TIMP), was delivered in complex with TIMP-1 or in a mixture with TIMP-2, the protease failed to rescue the inhibitory effects of anti-IL8 therapy, indicating that the TIMP-free status of proMMP-9 is critical for facilitating tumor angiogenesis and intravasation. Our findings directly link tumor-associated neutrophils and their TIMP-free proMMP-9 with the ability of aggressive tumor cells to induce the formation of new blood vessels that serve as conduits for tumor cell dissemination. Thus, treatment of cancers associated with neutrophil infiltration may benefit from specific targeting of neutrophil MMP-9 at early stages to prevent ensuing tumor angiogenesis and tumor metastasis.
authors: Department of Cell Biology, The Scripps Research Institute, La Jolla, California, USA.
authors: Erin M
authors: EM
authors: Bekes
authors: Bernhard
authors: B
authors: Schweighofer
authors: Tatyana A
authors: TA
authors: Kupriyanova
authors: Ewa
authors: E
authors: Zajac
authors: Veronica C
authors: VC
authors: Ardi
authors: James P
authors: JP
authors: Quigley
authors: Elena I
authors: EI
authors: Deryugina
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002642:Chick Embryo; D004792:Enzyme Precursors / Q000378:metabolism*; D005354:Fibrosarcoma / Q000098:blood supply / Q000378:metabolism / Q000556:secondary; D006801:Humans; D016209:Interleukin-8 / Q000494:pharmacology; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D051379:Mice; D008819:Mice, Nude; D016513:Mice, SCID; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000201:enzymology*; D009504:Neutrophils / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000098:blood supply / Q000378:metabolism; D019714:Tissue Inhibitor of Metalloproteinases / Q000502:physiology*
chemical_list: D004792:Enzyme Precursors; D016209:Interleukin-8; D019714:Tissue Inhibitor of Metalloproteinases; C120487:pro-matrix metalloproteinase 9; D020780:Matrix Metalloproteinase 9